(Q40574222)

21 September 2017

title

In vitro determination of dengue virus type 2 NS2B-NS3 protease activity with fluorescent peptide substrates (English)

1 reference

21 September 2017

1 reference

dengue NS2B-NS3 protease

1 reference

based on heuristic

inferred from abstract

author name string

Rabuesak Khumthong

1

1 reference

21 September 2017

Chanan Angsuthanasombat

2

1 reference

21 September 2017

Sakol Panyim

3

1 reference

21 September 2017

Gerd Katzenmeier

4

1 reference

21 September 2017

publication date

1 March 2002

1 reference

21 September 2017

1 reference

21 September 2017

volume

35

1 reference

21 September 2017

issue

2

1 reference

21 September 2017

page(s)

206-212

1 reference

Dengue and dengue haemorrhagic fever

21 September 2017

cites work

1 reference

https://api.crossref.org/works/10.5483/BMBREP.2002.35.2.206

Dengue: the risk to developed and developing countries

4 November 2022

1 reference

https://api.crossref.org/works/10.5483/BMBREP.2002.35.2.206

Live attenuated tetravalent dengue vaccine

4 November 2022

1 reference

https://api.crossref.org/works/10.5483/BMBREP.2002.35.2.206

Flavivirus premembrane protein cleavage and spike heterodimer secretion require the function of the viral proteinase NS3.

4 November 2022

1 reference

https://api.crossref.org/works/10.5483/BMBREP.2002.35.2.206

Purified NS2B/NS3 serine protease of dengue virus type 2 exhibits cofactor NS2B dependence for cleavage of substrates with dibasic amino acids in vitro

4 November 2022

1 reference

https://api.crossref.org/works/10.5483/BMBREP.2002.35.2.206

Crystal structure of the hepatitis C virus NS3 protease domain complexed with a synthetic NS4A cofactor peptide

4 November 2022

1 reference

https://api.crossref.org/works/10.5483/BMBREP.2002.35.2.206

Detection of a trypsin-like serine protease domain in flaviviruses and pestviruses

4 November 2022

1 reference

https://api.crossref.org/works/10.5483/BMBREP.2002.35.2.206

Dengue 2 virus NS2B and NS3 form a stable complex that can cleave NS3 within the helicase domain

4 November 2022

1 reference

https://api.crossref.org/works/10.5483/BMBREP.2002.35.2.206

Chimeric dengue type 2 (vaccine strain PDK-53)/dengue type 1 virus as a potential candidate dengue type 1 virus vaccine

4 November 2022

1 reference

https://api.crossref.org/works/10.5483/BMBREP.2002.35.2.206

Flavivirus genome organization, expression, and replication

4 November 2022

1 reference

https://api.crossref.org/works/10.5483/BMBREP.2002.35.2.206

Analyses of the terminal sequences of West Nile virus structural proteins and of the in vitro translation of these proteins allow the proposal of a complete scheme of the proteolytic cleavages involved in their synthesis

4 November 2022

1 reference

https://api.crossref.org/works/10.5483/BMBREP.2002.35.2.206

Crystal structure of Dengue virus NS3 protease in complex with a Bowman-Birk inhibitor: implications for flaviviral polyprotein processing and drug design

4 November 2022

1 reference

https://api.crossref.org/works/10.5483/BMBREP.2002.35.2.206

Cleavage specificity of human rhinovirus-2 2A protease for peptide substrates

4 November 2022

1 reference

https://api.crossref.org/works/10.5483/BMBREP.2002.35.2.206

Dengue virus NS3 serine protease. Crystal structure and insights into interaction of the active site with substrates by molecular modeling and structural analysis of mutational effects

4 November 2022

1 reference

https://api.crossref.org/works/10.5483/BMBREP.2002.35.2.206

Construction of infectious cDNA clones for dengue 2 virus: strain 16681 and its attenuated vaccine derivative, strain PDK-53.

4 November 2022

1 reference

https://api.crossref.org/works/10.5483/BMBREP.2002.35.2.206

10.5483/BMBREP.2002.35.2.206

4 November 2022

Identifiers

DOI

1 reference

21 September 2017

1 reference